Specifically, Mxd3 overexpression leads to the progression of NAFLD phenotypes, including NASH, fibrosis, and HCC (Figure 6 and Figure 7). The gene discussed is MXD3; the disease is metabolic dysfunction-associated steatotic liver disease.